CN104606610A - Oral buccal tablet for later-period regulation of chronic bronchitis - Google Patents
Oral buccal tablet for later-period regulation of chronic bronchitis Download PDFInfo
- Publication number
- CN104606610A CN104606610A CN201510070874.9A CN201510070874A CN104606610A CN 104606610 A CN104606610 A CN 104606610A CN 201510070874 A CN201510070874 A CN 201510070874A CN 104606610 A CN104606610 A CN 104606610A
- Authority
- CN
- China
- Prior art keywords
- buccal tablet
- extract
- chronic bronchitis
- oral
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses an oral buccal tablet for later-period regulation of chronic bronchitis. The total composition of the oral buccal comprises medical components with the weight ratio being 9%-20% and the effect of killing pyogenic coccus and bacillus; the medical components are extracts of euphorbia pekinensis, violae, notopterygium root and galanga; in the total composition of the buccal tablet, the weight percent of the euphornin is more than or equal to 0.01%, the weight percent of flavonoid glycosides is more than or equal to 0.01%, the weight percent of the columbianetin is more than or equal to 0.02%, and the weight percent of methyl cinnamate is more than or equal to 0.008%. The oral buccal tablet disclosed by the invention has the advantages that pathogenic bacterium of nasosinusitis in an oral cavity can be effectively killed and the pathogenic bacterium in the oral cavity can be prevented from infecting the bronchia.
Description
Technical field
The present invention relates to conditioning of a kind of chronic bronchitis later stage oral buccal tablet.
Background technology
Dental care product is indispensable cleaning supplies in people's daily life, and this series products is of a great variety, comprises buccal tablet, dentifrice, cleaning agent for mouth cavity etc., is mainly used in keeping the cleaning of oral cavity, promotes breath freshening, safeguards good oral environment.But up to the present, not yet there is a oral buccal tablet used for the conditioning of chronic bronchitis later stage.
Chronic bronchitis (abbreviation chronic bronchitis) refers to the chronic nonspecific inflammation of trachea-bronchial epithelial cell mucosa and surrounding tissue thereof.Clinically with cough, expectoration or with pant and the chronic process of recurrent exerbation for feature.It is a kind of commonly encountered diseases of serious harm people ' s health, especially common with old people.
Chronic bronchitis is a kind of disease needing long-term medical simultaneously, and needs of patients long-term prescription just can make the state of an illness be controlled.At present, the method for the treatment of chronic bronchitis mainly contains and takes the medicament containing antibiotic composition orally is main.
But, current research finds, the why cureless major reason of chronic bronchitis be because pathogenic flora can in oral cavity flourish, environment moistening in oral cavity be very applicable to pyococcus (as streptococcus pneumoniae, Hemolytic Type streptococcus, staphylococcus, micrococcus catarrhalis), bacillus (as hemophilus influenza, Bacillus proteus and escherichia coli) flourish.Find that rear food debris easily remains in oral cavity on the feed by great many of experiments and improve good breeding place to pathogenic bacterium, after feed, in a few hours, pathogenic bacterium start amount reproduction.Oral cavity, trachea communicate with each other, pathogenic bacterium can be propagated mutually between the two, existing Therapeutic Method is that simple use antibiotic is killed pathogenic bacterium, non-boil on the nape opposite the mouth intracavity pathogenic bacterium are killed, when in bronchus, pathogenic bacteria is killed, intraoral pathogenic bacterium to its repeated infection, can cause the obstinate of chronic bronchitis again.
At present, market not yet there is a oral buccal tablet used for the conditioning of chronic bronchitis later stage.
Summary of the invention
The object of this invention is to provide the oral buccal tablet that the conditioning of a kind of chronic bronchitis later stage uses, this buccal tablet contains the ingredient killing pyococcus, bacillus, can effectively kill this type of pathogenic bacterium.
The oral buccal tablet that chronic bronchitis later stage conditioning of the present invention uses, include in its buccal tablet total composition weight ratio be 9% ~ 20% there is the ingredient killing pyococcus, bacillus, described ingredient is the extract of the Radix Euphorbiae Pekinensis, Herba Violae, Rhizoma Et Radix Notopterygii, Rhizoma Alpiniae Officinarum; Euphorbon detects composition as the quality control of Radix Euphorbiae Pekinensis extract effective ingredient; Flavonoid glycoside detects composition as the quality control of Herba Violae extract effective ingredient; Columbianetin detects composition as the quality control of Rhizoma Seu Radix Notopterygii extract effective ingredient; Methyl cinnamate detects composition as the quality control of Rhizoma Alpiniae Officinarum extract effective ingredient; In described buccal tablet total composition, euphorbon is at percentage by weight >=0.01% of the total constituent of buccal tablet, flavonoid glycoside is at percentage by weight >=0.01% of the total constituent of buccal tablet, columbianetin is at percentage by weight >=0.02% of the total constituent of buccal tablet, and methyl cinnamate is at percentage by weight >=0.008% of the total constituent of buccal tablet.
The oral buccal tablet that above-mentioned chronic bronchitis later stage conditioning uses more specifically scheme can be: the extract of the described Radix Euphorbiae Pekinensis is euphorbon extract, the extract of described Herba Violae is flavonoid glycoside extract, the extract of described Rhizoma Et Radix Notopterygii is columbianetin extract, the extract of described Rhizoma Alpiniae Officinarum is methyl cinnamate extract, the usage ratio of these four kinds of Chinese medicine extract is chosen by respective former medicine ratio, the former medicine in the Radix Euphorbiae Pekinensis: the former medicine of Herba Violae: the former medicine of Rhizoma Et Radix Notopterygii: the former medicine=1:1:2:1 of Rhizoma Alpiniae Officinarum:.
Below feature and the control effect and mechanism of each component is introduced respectively.
The Radix Euphorbiae Pekinensis: bitter in the mouth, cold in nature.Main component has euphorbon, alkaloid, euphorbia, and wherein euphorbon has inhibitory action to staphylococcus and bacillus pyocyaneus.
Herba Violae: bitter in the mouth, cold in nature.The flavonoid glycoside contained has very strong killing action to staphylococcus aureus, Staphylococcus albus, Bacillus proteus.
Rhizoma Et Radix Notopterygii: bitter in the mouth, warm in nature.Main component is Coumarins compound, and wherein columbianetin effectively can kill hemophilus influenza.
Rhizoma Alpiniae Officinarum: acrid in the mouth, hot in nature.Main component is methyl cinnamate, eugenol, pinene, cadinene, and wherein methyl cinnamate all has antibacterial action to Hemolytic streptococcus, streptococcus pneumoniae, staphylococcus aureus, Staphylococcus albus.
Detailed description of the invention
One, the preparation of pathogenic bacterium composition is killed
Euphorbon extract: flavonoid glycoside extract: columbianetin extract: methyl cinnamate extract=1:1:2:1.
Two, the oral buccal tablet that the conditioning of chronic bronchitis later stage uses is prepared
The oral buccal tablet adopting the chronic bronchitis later stage conditioning of mentioned component preparation to use, only needs above-mentioned sterilization component to be dispersed in uniformly during other constituent makes.
Three, case of illness introduce
Gold certain, man, 40 years old, be diagnosed as chronic bronchitis.Use buccal tablet of the present invention, every day 3 times (3 meal are taken food rear), within 12nd, check, the state of an illness is clearly better, and bronchus redness disappears, and adheres to using rear inspection for 30th, bronchial disorders recovery from illness.
Field, man, 10 years old, is diagnosed as chronic bronchitis.Use buccal tablet of the present invention, every day 3 times (after 3 meal feeds), within 15th, check, the state of an illness is clearly better, and bronchiectasis symptom is clearly better, and adheres to using rear inspection for 30th, and the inflammation such as bronchiectasis disappear completely.
Claims (2)
1. a chronic bronchitis later stage conditioning oral buccal tablet, it is characterized in that: including weight ratio in buccal tablet total composition is 9% ~ 20% have and kill pyococcus, the ingredient of bacillus, described ingredient is the Radix Euphorbiae Pekinensis, Herba Violae, Rhizoma Et Radix Notopterygii, the extract of Rhizoma Alpiniae Officinarum, in described buccal tablet total composition, euphorbon is at percentage by weight >=0.01% of the total constituent of buccal tablet, flavonoid glycoside is at percentage by weight >=0.01% of the total constituent of buccal tablet, columbianetin is at percentage by weight >=0.02% of the total constituent of buccal tablet, methyl cinnamate is at percentage by weight >=0.008% of the total constituent of buccal tablet.
2. chronic bronchitis later stage conditioning oral buccal tablet according to claim 1, it is characterized in that: the extract of the described Radix Euphorbiae Pekinensis is euphorbon extract, the extract of described Herba Violae is flavonoid glycoside extract, the extract of described Rhizoma Et Radix Notopterygii is columbianetin extract, the extract of described Rhizoma Alpiniae Officinarum is methyl cinnamate extract, the usage ratio of these four kinds of Chinese medicine extract is chosen by respective former medicine ratio, the former medicine in the Radix Euphorbiae Pekinensis: the former medicine of Herba Violae: the former medicine of Rhizoma Et Radix Notopterygii: the former medicine=1:1:2:1 of Rhizoma Alpiniae Officinarum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510070874.9A CN104606610A (en) | 2015-02-11 | 2015-02-11 | Oral buccal tablet for later-period regulation of chronic bronchitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510070874.9A CN104606610A (en) | 2015-02-11 | 2015-02-11 | Oral buccal tablet for later-period regulation of chronic bronchitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104606610A true CN104606610A (en) | 2015-05-13 |
Family
ID=53141431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510070874.9A Pending CN104606610A (en) | 2015-02-11 | 2015-02-11 | Oral buccal tablet for later-period regulation of chronic bronchitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104606610A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922575A (en) * | 2015-05-30 | 2015-09-23 | 李�杰 | Buccal tablet suitable for patients with bronchitis |
| CN107281426A (en) * | 2017-06-25 | 2017-10-24 | 赵敏 | The lozenge that partner treatment bronchitis is used |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103070813A (en) * | 2013-02-17 | 2013-05-01 | 李宝 | Toothpaste applicable to chronic sinusitis patients |
| CN104042515A (en) * | 2014-06-27 | 2014-09-17 | 李�杰 | Toothpaste suitable for allergic sinusitis patient |
| CN104258242A (en) * | 2014-09-29 | 2015-01-07 | 李宝 | Bactericide applicable to patients suffering from allergic rhinitis |
-
2015
- 2015-02-11 CN CN201510070874.9A patent/CN104606610A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103070813A (en) * | 2013-02-17 | 2013-05-01 | 李宝 | Toothpaste applicable to chronic sinusitis patients |
| CN104042515A (en) * | 2014-06-27 | 2014-09-17 | 李�杰 | Toothpaste suitable for allergic sinusitis patient |
| CN104258242A (en) * | 2014-09-29 | 2015-01-07 | 李宝 | Bactericide applicable to patients suffering from allergic rhinitis |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922575A (en) * | 2015-05-30 | 2015-09-23 | 李�杰 | Buccal tablet suitable for patients with bronchitis |
| CN107281426A (en) * | 2017-06-25 | 2017-10-24 | 赵敏 | The lozenge that partner treatment bronchitis is used |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105148253B (en) | Skin and mucosa bactericidal composition | |
| US11801275B2 (en) | Compositions and methods for common colds | |
| CN103340974B (en) | Oral care aerosol and preparation method thereof | |
| CN103070813A (en) | Toothpaste applicable to chronic sinusitis patients | |
| CN107029210A (en) | Wood frog's fallopian tube antibacterial peptide oral spray | |
| CN104042515A (en) | Toothpaste suitable for allergic sinusitis patient | |
| CN104825367A (en) | Toothpaste capable of treating bronchitis | |
| CN104523527A (en) | Toothpaste suitable for patient with chronic bronchitis | |
| CN104027701A (en) | Oral cavity antibacterial spray suitable for anaphylactic rhinitis patients | |
| CN101797269A (en) | Physiological balance liquid for adjusting microecology in vaginas of women | |
| CN104606610A (en) | Oral buccal tablet for later-period regulation of chronic bronchitis | |
| CN104922575A (en) | Buccal tablet suitable for patients with bronchitis | |
| CN104587346A (en) | Lozenge indicated to patients with chronic sinusitis | |
| CN110787078A (en) | Toothpaste containing licoflavone and preparation method and application thereof | |
| CN104258242A (en) | Bactericide applicable to patients suffering from allergic rhinitis | |
| CN104324062A (en) | American ginseng conversion saponin, traditional Chinese medicine mouth care composition thereof and preparation method and application | |
| KR102468406B1 (en) | A ANTIBACTERIAL AND ANTIVIRUS COMPOSITION COMPRISING Extract of CANNABIS SATIVA L. | |
| CN105878227A (en) | Pharmaceutical composition for treating staphylococcus aureus infection | |
| JPH01172340A (en) | Preventive and remedy for staphylococcal disease of chicken | |
| CN106038410A (en) | Toothpaste having strong sterilizing function | |
| WO2013100774A1 (en) | Pharmaceutical compositions containing herbal based active ingredients for application in human and veterinary medicine | |
| CN105031477A (en) | Oral cavity and esophagus sterilization agent after swimming | |
| CN104689075B (en) | Treat the united medicine of Chinese and Western medicine of pressure sore | |
| Pachori et al. | Antimicrobial studies of herbs and shrubs against dental pathogens | |
| WO2024016109A1 (en) | Oral care composition of tea active substance and method for preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150513 |